BETHKIS (Chiesi USA, Inc.)
Welcome to the PulseAid listing for the BETHKIS drug offered from Chiesi USA, Inc.. This Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Chiesi USA, Inc. |
| NON-PROPRIETARY NAME: | tobramycin |
| SUBSTANCE NAME: | TOBRAMYCIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] |
| ROUTE: | RESPIRATORY (INHALATION) |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2013-04-15 |
| END MARKETING DATE: | 0000-00-00 |
BETHKIS HUMAN PRESCRIPTION DRUG Details:
| Item Description | BETHKIS from Chiesi USA, Inc. |
| LABELER NAME: | Chiesi USA, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300(mg/4mL) |
| START MARKETING DATE: | 2013-04-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 10122-820_76030f93-09fc-43b6-b86c-6f710bc9c922 |
| PRODUCT NDC: | 10122-820 |
| APPLICATION NUMBER: | NDA201820 |
Other TOBRAMYCIN Pharmaceutical Manufacturers / Labelers:
